Akums Drugs and Pharmaceuticals informs about updates
Akums Drugs and Pharmaceuticals has informed that Maxcure Nutravedics, a wholly-owned subsidiary of Akums Drugs & Pharmaceuticals, has received another order from the Office of the Deputy Commissioner of State Tax, Gujarat, imposing an additional penalty of INR 1,79,55,000/- under Section 129(3) of the CGST Act, 2017, over and above the penalty already disclosed on 15th December, 2025. Details required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with the SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 are provided herein as Annexure-A.
The above information is a part of company’s filings submitted to BSE.
